Skip to main content

Table 3 Cost effectiveness of ART programme provision in Zambia

From: Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia

Programme

Cost (USD)

Incremental cost

Effectiveness (QALYs)

Incremental effectiveness

ICER (USD/QALYs)

Cost/effectiveness

Decision

Original (hospital only)

1259.16

 

6.81

0

0

184.78

Undominated

Intervention (hospital + mobile)

2601.02

1341.86

7.27

0.45

2965.17

357.93

Undominated

  1. The mean annual per-patient costs were 1259.16 USD for the original programme and 2601.02 USD for the intervention programme. The mean number of quality-adjusted life years (QALYs) was 6.81 for the original and 7.27 for the intervention programmes. The cost-effectiveness ratio was higher for the intervention programme (357.93 USD/QALY) than for the original programme (184.78 USD/QALY). The ICER of the intervention programme relative to the original programme was 2965.17 USD/QALY